![]() |
Peptimmune Announces Second Grant Of A United States Patent For PI-2301 Peptide Copol
Peptimmune, Inc. a privately held biotechnology company, announced the grant of US Patent Number 7,655,221 (the '221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases. The '221 patent claims important treatment modalities for PI-2301 and related compounds...
للمزيد... |
| حسب توقيت السعودية الساعة الآن:04:56 am. |
Powered by vBulletin V3.8.5. Copyright ©2000 - 2010
MS-Saudi.com/MS-Saudi.org Copyright ©2004 - 2010